PMID- 9839864 OWN - NLM STAT- MEDLINE DCOM- 19990204 LR - 20061115 IS - 0928-7329 (Print) IS - 0928-7329 (Linking) VI - 6 IP - 2-3 DP - 1998 Sep TI - Protein and cell engineering of components of the human immunoglobulin E receptor/effector system: applications for therapy and diagnosis. PG - 195-207 AB - Adaptive immune responses characterised by the synthesis of antibodies of the immunoglobulin E (IgE) isotype play an important role in type I hypersensitivity disorders and parasitic infestations, diseases which have an significant socioeconomic impact world-wide. This paper considers potential applications of recent advances in our understanding of the origin of isotype specific immune responses which emerged as a result of cell and protein engineering studies on components of the human IgE/receptor/effector system. Furthermore, the identification of the receptor binding regions in IgE as a result of the development of a stable assay system has important applications for the design of rational therapeutic interventions in allergy and asthma, the treatment of mast cell tumours, and the establishment of procedures for the selective isolation of cells expressing the high-affinity receptor for IgE for functional studies. FAU - Helm, B A AU - Helm BA AD - Krebs Institute for Biomolecular Research, Department of Molecular Biology and Biotechnology, The University of Sheffield, UK. B.Helm@Sheffield.AC.UK FAU - Sayers, I AU - Sayers I FAU - Swan, J AU - Swan J FAU - Smyth, L J AU - Smyth LJ FAU - Cain, S A AU - Cain SA FAU - Suter, M AU - Suter M FAU - Machado, D C AU - Machado DC FAU - Spivey, A C AU - Spivey AC FAU - Padlan, E A AU - Padlan EA LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - Netherlands TA - Technol Health Care JT - Technology and health care : official journal of the European Society for Engineering and Medicine JID - 9314590 RN - 0 (Antibodies) RN - 0 (Receptors, IgE) RN - 37341-29-0 (Immunoglobulin E) SB - IM MH - Animals MH - Antibodies/*chemistry MH - Cell Line MH - *Drug Design MH - Humans MH - Hypersensitivity, Immediate/diagnosis/*immunology/therapy MH - Immunoglobulin E/*chemistry/*immunology MH - Mast Cells/immunology MH - Parasitic Diseases/diagnosis/*immunology/therapy MH - Protein Engineering/*methods MH - Rats MH - Receptors, IgE/*chemistry EDAT- 1998/12/05 00:00 MHDA- 1998/12/05 00:01 CRDT- 1998/12/05 00:00 PHST- 1998/12/05 00:00 [pubmed] PHST- 1998/12/05 00:01 [medline] PHST- 1998/12/05 00:00 [entrez] PST - ppublish SO - Technol Health Care. 1998 Sep;6(2-3):195-207.